Overall survival | HR (95% CI) | p-value |
---|---|---|
FT Group | Ā | Ā |
āB-FT vs. NO-FT | 6.0 (2.0 ā 18.6) | 0.0013 |
āDA-FT vs. NO-FT | 1.5 (0.4 ā 5.4) | |
Age (years) | Ā | Ā |
āā„50 vs. < 50 | 2.1 (0.8 ā 5.3) | 0.1165 |
Smoking | Ā | Ā |
ā<20 pack-years vs. never smoker | 3.6 (0.8 ā 16.9) | 0.0182 |
āā„20 pack-years vs. never smoker | 5.0 (1.6 ā 15.3) | |
Disease Free Survival | Ā | Ā |
FT Group | Ā | Ā |
āB-FT vs. NO-FT | 4.7 (1.7 ā 13.1) | 0.0017 |
āDA-FT vs. NO-FT | 1.3 (0.4 ā 4.0) | |
Age (years) | Ā | Ā |
āā„50 vs. < 50 | 2.3 (1.0 ā 5.4) | 0.0619 |
Smoking | Ā | Ā |
ā<20 pack-years vs. never smoker | 2.2 (0.5 ā 9.5) | 0.0316 |
āā„20 pack-years vs. never smoker | 3.8 (1.4 ā 10.6) | |
Distant Metastases Free Survival | Ā | Ā |
Group | Ā | Ā |
āB-FT vs. NO-FT | 0.91 (0.17 ā 5.02) | 0.9942 |
āDA-FT vs. NO-FT | 0.95 (0.21 ā 4.27) | |
Age (years) | Ā | Ā |
āā„50 vs. < 50 | 3.7 (0.8 ā 17.8) | 0.1053 |